Through our Cox analysis we identified that, after adjusting for these effects, the use of antiplatelet therapy at baseline was a significant, independent predictor of the incidence of major vascular events (p<0??0001) and that there was a significant interaction between antiplatelet therapy and treatment with B vitamins on the primary outcome (adjusted p for interaction=0??0204), stroke (adjusted